Multiple Firms Initiate Coverage On TaskUs
BofA, William Blair, Baird, Wells Fargo, RBC Capital, Morgan Stanley, and Goldman Sachs initiated coverage of business process outsourcing services provider TaskUs Inc (NASDAQ: TASK).
Roth Capital Initiates Coverage On Zeta Global Holdings with Buy Rating, Announces Price Target of $16.5
Roth Capital analyst Richard Baldry initiates coverage on Zeta Global Holdings (NYSE:ZETA) with a Buy rating and announces Price Target of $16.5.
B of A Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $35
B of A Securities analyst Geoff Meacham initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price Target of $35.
B of A Securities Initiates Coverage On TaskUs with Buy Rating, Announces Price Target of $41
B of A Securities analyst Jason Kupferberg initiates coverage on TaskUs (NASDAQ:TASK) with a Buy rating and announces Price Target of $41.
Piper Sandler Initiates Coverage On Tempest Therapeutics with Overweight Rating, Announces Price Target of $23
Piper Sandler analyst Edward Tenthoff initiates coverage on Tempest Therapeutics (NASDAQ:TPST) with a Overweight rating and announces Price Target of $23.
UBS Initiates Coverage On LifeStance Health Group with Buy Rating, Announces Price Target of $34
UBS analyst Kevin Caliendo initiates coverage on LifeStance Health Group (NASDAQ:LFST) with a Buy rating and announces Price Target of $34.
Oppenheimer Initiates Coverage On Zeta Global Holdings with Perform Rating
Oppenheimer analyst Brian Schwartz initiates coverage on Zeta Global Holdings (NYSE:ZETA) with a Perform rating.
Wolfe Research Initiates Coverage On Marqeta with Peer Perform Rating
Wolfe Research analyst Darrin Peller initiates coverage on Marqeta (NASDAQ:MQ) with a Peer Perform rating.
William Blair Initiates Coverage On TaskUs with Outperform Rating
William Blair analyst Maggie Nolan initiates coverage on TaskUs (NASDAQ:TASK) with a Outperform rating.
Cantor Fitzgerald Initiates Coverage On Hyliion Holdings with Overweight Rating, Announces Price Target of $17
Cantor Fitzgerald analyst Josh Cohen initiates coverage on Hyliion Holdings (NYSE:HYLN) with a Overweight rating and announces Price Target of $17.